Purchase Order 75N95023P00677

Award Date 8/31/23
Potential Completion Date 10/1/23
Potential Value $25K
Contracting Federal Agency
National Institute on Drug Abuse
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Carlsbad, CA 92008, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This $57,000 firm-fixed-price purchase order was awarded to Life Technologies Corporation, a for-profit manufacturer of scientific instruments, reagents, and consumables. The award is not associated with a set-aside program. Life Technologies Corporation, as the prime contractor, will provide the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH), with specialized biotechnology products, genetic analysis technologies, and...
The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences awarded a $12,000 purchase order contract to Life Technologies Corporation. The contract has a period of performance from December 6, 2023 through January 6, 2024 for products or services to be delivered to a location in Grand Island, New York. As the prime contractor, Life Technologies Corporation will fulfill the contract requirements without the use of major...
The National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH), awarded a $23,940.00 firm-fixed-price purchase order to Life Technologies Corporation, a division of Thermo Fisher Scientific, for a View RNA in situ hybridization (ISH) cell assay kit. This acquisition supports NCATS' Cooperative Research and Development Agreement (CRADA) for Alagille syndrome (ALGS) research, specifically to screen compound libraries for activators of the...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a firm fixed price purchase order to Life Technologies Corporation of Carlsbad, California. With a period of performance from September 2020 through December 2023, this $20 million contract supports NIH/NCI's mission to conduct and fund cancer research by providing life science research products and services. As a leading supplier of innovative tools for scientific discovery and biomedical...
The Department of Health and Human Services National Institutes of Health Office of Logistics and Acquisition Operations awarded a $35,000 firm fixed price purchase order to Life Technologies Corporation of Carlsbad, California. Life Technologies Corporation, a subsidiary of Thermo Electron Corporation Financial Services Division, will provide unspecified products or services to the agency under this contract, which runs from August 3rd to August 30th, 2023. The award draws from the HHS-NIH's...
This is a firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the U.S. Department of Health and Human Services, to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables. The $24,262.29 contract is for the delivery of primary human hepatocytes, which are a critical reagent used in biomedical research supported by NCATS. This contract is not associated with any set-aside...
This firm-fixed-price purchase order was awarded by the Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables. The $236,257.60 contract is for the delivery of products and services to support the agency's biomedical research, applied markets, and forensic analysis initiatives. Life Technologies has provided genetic...
The Department of Health and Human Services' National Institutes of Health National Institute of Child Health and Human Development awarded a $32,445 firm fixed price purchase order to Life Technologies Corporation of Carlsbad, California. As a subsidiary of Thermo Electron Corporation Financial Services Division, Life Technologies will provide products or services to NIH under this contract through September 30, 2016 in support of NICHD's research efforts. No additional details were provided on...
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a Firm Fixed Price Purchase Order worth $106,172.66 to Life Technologies Corporation, a for-profit manufacturer of scientific instruments, reagents, and consumables. The contract has a completion date of February 28, 2019 and does not utilize any set-asides. As a division of Thermo Fisher Scientific, Life Technologies has delivered genetic analyzers, reagents, assays, instruments,...
This is a $12,561 firm fixed-price purchase order contract awarded by the Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences (NCATS) to Life Technologies Corporation, a for-profit manufacturer of scientific instruments, reagents, and consumables. The contract is for the delivery of ESSENTIAL 6 - MEDIUM RAPID PROTOTYPING LIQUID (BAG) for NCATS, with a completion date of April 17, 2024. This contract was not set aside for...

The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences awarded a $24,512.25 firm fixed-price purchase order to Life Technologies Corporation of Carlsbad, California. As the prime contractor, Life Technologies will provide products or services to NIH NCATS between August 31 and October 1, 2023. The award is not associated with a multiple award contract vehicle. No subcontractors or set aside designations were indicated. NCATS' mission involves accelerating the development and testing of new drugs and therapies, so this purchase order is likely in support of the Center's research and development activities.

Generated 12/19/23, 7:38 PM